Voorde, J. V. Et Al. 2014. Nucleoside-catabolizing enzymes in mycoplasma-infected tumor cell cultures compromise the cytostatic activity of the anticancer drug gemcitabine. Journal of Biological Chemistry , vol.289, no.19 , 13054-13065.

Voorde, J. V., Sabuncuoǧlu, S., Noppen, S., Hofer, A., Ranjbarian, F., Fieuws, S., ... Balzarini, J.(2014). Nucleoside-catabolizing enzymes in mycoplasma-infected tumor cell cultures compromise the cytostatic activity of the anticancer drug gemcitabine. Journal of Biological Chemistry , vol.289, no.19, 13054-13065.

Voorde, Johan Et Al. "Nucleoside-catabolizing enzymes in mycoplasma-infected tumor cell cultures compromise the cytostatic activity of the anticancer drug gemcitabine," Journal of Biological Chemistry , vol.289, no.19, 13054-13065, 2014

Voorde, Johan V. Et Al. "Nucleoside-catabolizing enzymes in mycoplasma-infected tumor cell cultures compromise the cytostatic activity of the anticancer drug gemcitabine." Journal of Biological Chemistry , vol.289, no.19, pp.13054-13065, 2014

Voorde, J. V. Et Al. (2014) . "Nucleoside-catabolizing enzymes in mycoplasma-infected tumor cell cultures compromise the cytostatic activity of the anticancer drug gemcitabine." Journal of Biological Chemistry , vol.289, no.19, pp.13054-13065.

@article{article, author={Johan Vande Voorde Et Al. }, title={Nucleoside-catabolizing enzymes in mycoplasma-infected tumor cell cultures compromise the cytostatic activity of the anticancer drug gemcitabine}, journal={Journal of Biological Chemistry}, year=2014, pages={13054-13065} }